Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Netflix, Inc. · NFLX · FY2026 Q2 · Calendar Q3 2026
Netflix delivered Q2 2026 results that narrowly beat on EPS ($0.80 vs. $0.79 estimate) while slightly missing on revenue ($12.56B vs. $12.58B estimate). The company reaffirmed its full-year 2026 revenue growth guidance of 13-14% (FX-neutral ~12%), with content spend growing approximately 10% slower than revenue. Management highlighted live events as a key subscriber acquisition and ad-revenue driver, even as view-hour growth showed modest deceleration. The stock dropped 7.3% in the session following the report, with volume 2.8x baseline, before partially recovering 2.1% in subsequent sessions. The sell-off appears tied to concerns about view-hour softness and FX-neutral growth deceleration, despite management's confident tone and disciplined capital return of $4.7B in Q2 buybacks. Netflix's self-reported 45% global household penetration and 5% of TV view share underscore the long-term…
Netflix, Inc. serves as a worldwide entertainment provider. Its comprehensive library features television series, motion pictures, documentaries, and mobile games, spanning numerous genres and languages. Members can effortlessly stream this content through a variety of internet-connected devices, including smart TVs, digital media players, cable boxes, and mobile phones. Furthermore, the company continues to offer a DVD-by-mail subscription service to its customers in the United States. With roughly 222 million paying subscribers distributed across 190 countries, Netflix was founded in 1997 and is headquartered in Los Gatos, California.
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 17, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jul 17, 2026 |
| UBS | Buy | Buy | Maintain | Jul 17, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 17, 2026 |
| Rosenblatt | Neutral | Neutral | Maintain | Jul 17, 2026 |
| Pivotal Research | Hold | Hold | Maintain | Jul 17, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 17, 2026 |
| KGI Securities | Neutral | Outperform | Downgrade | Jul 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 17, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 17, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 17, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 9, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 18, 2026 |
| Citizens | Market Perform | Market Perform | Maintain | Apr 17, 2026 |
| CFRA | Buy | Hold | Upgrade | Mar 6, 2026 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Jan 27, 2026 |
| Freedom Broker | Buy | Hold | Upgrade | Jan 27, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 22, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Jan 21, 2026 |
| Needham | Buy | Buy | Maintain | Jan 21, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 21, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jan 21, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jan 21, 2026 |
| Jefferies | Buy | Buy | Maintain | Dec 11, 2025 |
| Benchmark | Hold | Hold | Maintain | Oct 22, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Oct 7, 2025 |
| Loop Capital | Buy | Hold | Upgrade | Sep 17, 2025 |
| Macquarie | Outperform | Outperform | Maintain | Apr 21, 2025 |
| MoffettNathanson | Buy | Neutral | Upgrade | Mar 17, 2025 |
| Redburn Atlantic | Buy | Buy | Maintain | Jul 19, 2024 |
| DZ Bank | Buy | Hold | Upgrade | Jan 25, 2024 |
| Truist Securities | Buy | Hold | Upgrade | Oct 19, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 20, 2023 |
| New Street Research | Neutral | Neutral | Maintain | Apr 17, 2023 |
| Societe Generale | Sell | Sell | Maintain | Nov 30, 2022 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Oct 25, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 19, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Sep 28, 2022 |
| Stifel | Buy | Hold | Upgrade | Jul 20, 2022 |
| Edward Jones | Hold | Buy | Downgrade | Apr 21, 2022 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Jan 21, 2022 |
| Raymond James | Perform | Market Perform | Maintain | Sep 9, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 17, 2020 |
| Imperial Capital | In Line | Outperform | Downgrade | Jul 6, 2020 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 22, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Oct 17, 2019 |
| Huber Research | Underweight | Overweight | Downgrade | Oct 17, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 17, 2019 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Oct 9, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Apr 17, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Apr 17, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 18, 2019 |
| B. Riley FBR | Sell | Neutral | Downgrade | May 5, 2018 |
| B. Riley | Neutral | Neutral | Maintain | Apr 17, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 16, 2018 |
| Aegis Capital | Hold | Hold | Maintain | Oct 16, 2017 |
| PiperJaffray | Overweight | Overweight | Maintain | May 25, 2017 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Apr 18, 2017 |
| Mizuho | Buy | Neutral | Upgrade | Jan 17, 2017 |
| Brean Capital | Buy | Buy | Maintain | Nov 21, 2016 |
| Axiom Capital | Sell | Sell | Maintain | Aug 29, 2016 |
| William Blair | Market Outperform | Market Perform | Upgrade | Aug 24, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Jul 19, 2016 |
| BTIG Research | Buy | Buy | Maintain | Jul 19, 2016 |
| BTIG | Buy | Buy | Maintain | Jul 19, 2016 |
| FBR Capital | Market Perform | Outperform | Downgrade | Feb 12, 2016 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Feb 5, 2016 |
| Drexel Hamilton | Buy | Buy | Maintain | Jan 14, 2016 |
| Topeka Capital | Buy | Buy | Maintain | Jun 8, 2015 |
| Topeka | Buy | Buy | Maintain | Jun 8, 2015 |
| Argus | Hold | Hold | Maintain | Mar 26, 2015 |
| Janney Montgomery Scott | Buy | Buy | Maintain | Feb 13, 2015 |
| Janney Capital | Buy | Buy | Maintain | Feb 13, 2015 |
| CRT Capital | Hold | Hold | Maintain | Jan 21, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Jun 10, 2014 |
| Hudson Square | Buy | Hold | Upgrade | Apr 10, 2014 |
| S&P Capital IQ | Hold | Sell | Upgrade | Jan 23, 2014 |
| FBN Securities | Outperform | Outperform | Maintain | Jan 14, 2014 |
| MKM Partners | Buy | Buy | Maintain | Oct 1, 2013 |
| Northland Securities | Market Perform | Underperform | Upgrade | Jul 19, 2013 |
| Northland Capital Markets | Market Perform | Underperform | Upgrade | Jul 19, 2013 |
| National Alliance Securities | Buy | Accumulate | Maintain | Apr 23, 2013 |
| National Alliance | Buy | Accumulate | Maintain | Apr 23, 2013 |
| Lazard | Buy | Neutral | Upgrade | Jan 24, 2013 |
| Albert Fried & Co. | Underweight | Underweight | Maintain | Jan 18, 2013 |
| Caris & Co. | Average | Upgrade | Dec 6, 2012 | |
| Albert Fried | Underperform | Underperform | Maintain | Nov 16, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | May 31, 2012 |
| Dougherty & Co. | Neutral | Neutral | Maintain | Apr 24, 2012 |
| Dougherty | Neutral | Neutral | Maintain | Apr 24, 2012 |
Upside is calculated against the persisted previous close $70.4. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Analyst unavailable | $90 | $68.67 | +27.8% | Jul 22, 2026 |
| Deutsche Bank | Analyst unavailable | $110 | $68.95 | +56.3% | Jul 20, 2026 |
| UBS | Analyst unavailable | $115 | $74.35 | +63.4% | Jul 17, 2026 |
| Rosenblatt Securities | Barton Crockett | $75 | $74.35 | +6.5% | Jul 17, 2026 |
| UBS | Analyst unavailable | $85 | $74.35 | +20.7% | Jul 17, 2026 |
| Piper Sandler | Thomas Champion | $85 | $74.35 | +20.7% | Jul 17, 2026 |
| KGI Securities | Analyst unavailable | $75 | $74.35 | +6.5% | Jul 17, 2026 |
| Guggenheim | Analyst unavailable | $75 | $74.35 | +6.5% | Jul 17, 2026 |
| Morgan Stanley | Sean Diffley | $83 | $74.35 | +17.9% | Jul 17, 2026 |
| Wells Fargo | Analyst unavailable | $80 | $74.35 | +13.6% | Jul 17, 2026 |
| Oppenheimer | Analyst unavailable | $85 | $74.35 | +20.7% | Jul 17, 2026 |
| Goldman Sachs | Analyst unavailable | $94 | $74.35 | +33.5% | Jul 17, 2026 |
| Bernstein | Analyst unavailable | $95 | $74.35 | +34.9% | Jul 17, 2026 |
| Barclays | Analyst unavailable | $85 | $73.83 | +20.7% | Jul 14, 2026 |
| Morgan Stanley | Analyst unavailable | $90 | $73.83 | +27.8% | Jul 14, 2026 |
| UBS | Analyst unavailable | $100 | $73.37 | +42.0% | Jul 13, 2026 |
| KeyBanc | Justin Patterson | $92 | $73.37 | +30.7% | Jul 13, 2026 |
| Bernstein | Analyst unavailable | $100 | $76.18 | +42.0% | Jul 8, 2026 |
| Seaport Global | Analyst unavailable | $119 | $98.2 | +69.0% | Apr 17, 2026 |
| Guggenheim | Analyst unavailable | $120 | $97.73 | +70.5% | Apr 17, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $107.79 | +70.5% | Apr 17, 2026 |
| Wolfe Research | Peter Supino | $107 | $107.79 | +52.0% | Apr 17, 2026 |
| Piper Sandler | Thomas Champion | $115 | $107.79 | +63.4% | Apr 17, 2026 |
| Barclays | Kannan Venkateshwar | $110 | $107.79 | +56.3% | Apr 17, 2026 |
| Pivotal Research | Jeffrey Wlodarczak | $96 | $107.79 | +36.4% | Apr 17, 2026 |
| KeyBanc | Justin Patterson | $115 | $103.16 | +63.4% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $115 | $102.05 | +63.4% | Apr 9, 2026 |
| Oppenheimer | Analyst unavailable | $135 | $93.43 | +91.8% | Mar 27, 2026 |
| Wells Fargo | Steven Cahall | $105 | $98.32 | +49.1% | Mar 9, 2026 |
| Loop Capital Markets | Saken Ismailov | $104 | $84.27 | +47.7% | Jan 27, 2026 |
| UBS | Analyst unavailable | $104 | $84.4 | +47.7% | Jan 27, 2026 |
| Argus Research | Analyst unavailable | $110 | $84.1 | +56.3% | Jan 22, 2026 |
| Susquehanna | Analyst unavailable | $112 | $84.55 | +59.1% | Jan 21, 2026 |
| UBS | Analyst unavailable | $120 | $83.71 | +70.5% | Jan 21, 2026 |
| Deutsche Bank | Bryan Kraft | $98 | $83.72 | +39.2% | Jan 21, 2026 |
| Oppenheimer | Analyst unavailable | $125 | $84.94 | +77.6% | Jan 21, 2026 |
| UBS | Analyst unavailable | $130 | $84.15 | +84.7% | Jan 21, 2026 |
| BMO Capital | Brian Pitz | $135 | $84.79 | +91.8% | Jan 21, 2026 |
| Guggenheim | Analyst unavailable | $130 | $87.26 | +84.7% | Jan 21, 2026 |
| Piper Sandler | Analyst unavailable | $103 | $87.26 | +46.3% | Jan 21, 2026 |
| Needham | Laura Martin | $120 | $85.04 | +70.5% | Jan 21, 2026 |
| Goldman Sachs | Eric Sheridan | $100 | $87.26 | +42.0% | Jan 21, 2026 |
| Morgan Stanley | Analyst unavailable | $110 | $87.26 | +56.3% | Jan 21, 2026 |
| KeyBanc | Analyst unavailable | $108 | $87.26 | +53.4% | Jan 21, 2026 |
| Canaccord Genuity | Analyst unavailable | $125 | $87.26 | +77.6% | Jan 21, 2026 |
| Redburn Partners | Hamilton Faber | $120 | $87.26 | +70.5% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $95 | $87.26 | +34.9% | Jan 21, 2026 |
| UBS | Analyst unavailable | $95 | $87.26 | +34.9% | Jan 21, 2026 |
| KeyBanc | Analyst unavailable | $110 | $88.05 | +56.3% | Jan 16, 2026 |
| Wedbush | Analyst unavailable | $115 | $89.3 | +63.4% | Jan 15, 2026 |
| HSBC | Mohammed Khallouf | $107 | $89.44 | +52.0% | Jan 12, 2026 |
| Goldman Sachs | Analyst unavailable | $112 | $90.53 | +59.1% | Jan 9, 2026 |
| CFRA | Analyst unavailable | $100 | $90.99 | +42.0% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $120 | $94.79 | +70.5% | Dec 18, 2025 |
| Wolfe Research | Analyst unavailable | $121 | $94.57 | +71.9% | Dec 15, 2025 |
| Jefferies | James Heaney | $134 | $94.17 | +90.3% | Dec 11, 2025 |
| Bernstein | Laurent Yoon | $125 | $96.71 | +77.6% | Dec 10, 2025 |
| UBS | Analyst unavailable | $142 | $95.98 | +101.7% | Dec 8, 2025 |
| Pivotal Research | Analyst unavailable | $105 | $100.24 | +49.1% | Dec 8, 2025 |
| Evercore ISI | Mark Mahaney | $138 | $103.22 | +96.0% | Dec 5, 2025 |
| Rosenblatt Securities | Barton Crockett | $152 | $107.49 | +115.9% | Nov 28, 2025 |
| KGI Securities | Analyst unavailable | $135 | $111.89 | +91.8% | Nov 3, 2025 |
| Argus Research | Analyst unavailable | $141 | $110.5 | +100.3% | Oct 23, 2025 |
| Wedbush | Analyst unavailable | $140 | $124.14 | +98.9% | Oct 22, 2025 |
| UBS | Analyst unavailable | $150 | $124.14 | +113.1% | Oct 22, 2025 |
| Morgan Stanley | Analyst unavailable | $150 | $122.01 | +113.1% | Oct 13, 2025 |
| UBS | Analyst unavailable | $142.5 | $116.33 | +102.4% | Oct 7, 2025 |
| Seaport Global | Analyst unavailable | $138.5 | $116.33 | +96.7% | Oct 6, 2025 |
| Loop Capital Markets | Analyst unavailable | $135 | $122.85 | +91.8% | Sep 17, 2025 |
| Jefferies | James Heaney | $150 | $121.13 | +113.1% | Jul 18, 2025 |
| Piper Sandler | Thomas Champion | $140 | $124.51 | +98.9% | Jul 11, 2025 |
| Needham | Laura Martin | $150 | $124.51 | +113.1% | Jul 11, 2025 |
| Barclays | Kannan Venkateshwar | $110 | $127.53 | +56.3% | Jul 9, 2025 |
| Robert W. Baird | Vikram Kesavabhotla | $130 | $119.15 | +84.7% | May 16, 2025 |
| Wolfe Research | Peter Supino | $134 | $119.15 | +90.3% | May 16, 2025 |
| Evercore ISI | Analyst unavailable | $115 | $98.79 | +63.4% | Apr 21, 2025 |
| Piper Sandler | Thomas Champion | $115 | $98.79 | +63.4% | Apr 21, 2025 |
| Guggenheim | Michael Morris | $115 | $97.3 | +63.4% | Apr 18, 2025 |
| MoffettNathanson | Robert Fishman | $115 | $97.3 | +63.4% | Apr 18, 2025 |
| FBN Securities | Matthew Thornton | $116.5 | $97.67 | +65.5% | Mar 27, 2025 |
| UBS | Analyst unavailable | $100 | $97.2 | +42.0% | Mar 24, 2025 |
| UBS | Analyst unavailable | $90.47 | $90.64 | +28.5% | Mar 6, 2025 |
| Bernstein | Laurent Yoon | $120 | $98.49 | +70.5% | Jan 24, 2025 |
| KeyBanc | Justin Patterson | $110 | $95.4 | +56.3% | Jan 23, 2025 |
| Needham | Laura Martin | $115 | $98.22 | +63.4% | Jan 22, 2025 |
| Barclays | Kannan Venkateshwar | $71.5 | $87.92 | +1.6% | Jan 14, 2025 |
| KeyBanc | Justin Patterson | $100 | $93.21 | +42.0% | Dec 24, 2024 |
| Morgan Stanley | Benjamin Swinburne | $105 | $88.96 | +49.1% | Dec 18, 2024 |
| Canaccord Genuity | Maria Ripps | $94 | $86.86 | +33.5% | Dec 2, 2024 |
| Evercore ISI | Mark Mahaney | $95 | $88.68 | +34.9% | Dec 2, 2024 |
| Guggenheim | Michael Morris | $82.5 | $74.91 | +17.2% | Oct 29, 2024 |
| Argus Research | Joseph Bonner | $84 | $75.92 | +19.3% | Oct 21, 2024 |
| Oppenheimer | Jason Helfstein | $82.5 | $68.76 | +17.2% | Oct 18, 2024 |
| BMO Capital | Brian Pitz | $82.5 | $68.76 | +17.2% | Oct 18, 2024 |
| Jefferies | James Heaney | $80 | $68.76 | +13.6% | Oct 18, 2024 |
| Rosenblatt Securities | Barton Crockett | $68 | $68.76 | -3.4% | Oct 18, 2024 |
| Goldman Sachs | Eric Sheridan | $75 | $68.76 | +6.5% | Oct 18, 2024 |
| Canaccord Genuity | Maria Ripps | $76 | $68.76 | +8.0% | Oct 18, 2024 |
| Morgan Stanley | Benjamin Swinburne | $83 | $68.76 | +17.9% | Oct 18, 2024 |
| Bernstein | Laurent Yoon | $78 | $68.76 | +10.8% | Oct 18, 2024 |
| Pivotal Research | Jeffrey Wlodarczak | $92.5 | $68.76 | +31.4% | Oct 18, 2024 |
| Evercore ISI | Mark Mahaney | $77.5 | $68.76 | +10.1% | Oct 17, 2024 |
| Piper Sandler | Matt Farrell | $84 | $68.76 | +19.3% | Oct 17, 2024 |
| UBS | John Hodulik | $82.5 | $68.76 | +17.2% | Oct 17, 2024 |
| KeyBanc | Justin Patterson | $78.5 | $68.76 | +11.5% | Oct 17, 2024 |
| Oppenheimer | Jason Helfstein | $77.5 | $69.42 | +10.1% | Oct 17, 2024 |
| Loop Capital Markets | Alan Gould | $80 | $70.6 | +13.6% | Oct 16, 2024 |
| Goldman Sachs | Eric Sheridan | $70.9 | $71.3 | +0.7% | Oct 14, 2024 |
| Citigroup | Jason Bazinet | $67.5 | $71.32 | -4.1% | Oct 14, 2024 |
| Guggenheim | Michael Morris | $81 | $73.03 | +15.1% | Oct 11, 2024 |
| Morgan Stanley | Benjamin Swinburne | $82 | $72.74 | +16.5% | Oct 10, 2024 |
| Deutsche Bank | Bryan Kraft | $65 | $72.18 | -7.7% | Oct 9, 2024 |
| Piper Sandler | Matt Farrell | $80 | $71.97 | +13.6% | Oct 7, 2024 |
| J.P. Morgan | Doug Anmuth | $75 | $69.71 | +6.5% | Sep 13, 2024 |
| Evercore ISI | Mark Mahaney | $75 | $68.84 | +6.5% | Aug 27, 2024 |
| Rosenblatt Securities | Barton Crockett | $63.5 | $63.33 | -9.8% | Jul 19, 2024 |
| BMO Capital | Brian Pitz | $77 | $64.82 | +9.4% | Jul 19, 2024 |
| Macquarie | Tim Nollen | $69.5 | $63.73 | -1.3% | Jul 19, 2024 |
| UBS | John Hodulik | $75 | $64.3 | +6.5% | Jul 19, 2024 |
| Piper Sandler | Matt Farrell | $65 | $64.3 | -7.7% | Jul 19, 2024 |
| Redburn Partners | Hamilton Faber | $76 | $64.3 | +8.0% | Jul 19, 2024 |
| Guggenheim | Michael Morris | $73.5 | $64.08 | +4.4% | Jul 18, 2024 |
| MoffettNathanson | Michael Nathanson | $56.5 | $64.76 | -19.7% | Jul 15, 2024 |
| Goldman Sachs | Eric Sheridan | $65 | $69.31 | -7.7% | Jul 9, 2024 |
| Argus Research | Joseph Bonner | $76.7 | $67.36 | +8.9% | Jul 2, 2024 |
| Loop Capital Markets | Alan Gould | $75 | $68.57 | +6.5% | Jun 18, 2024 |
| KeyBanc | Justin Patterson | $70.7 | $65.23 | +0.4% | Jun 13, 2024 |
| Evercore ISI | Mark Mahaney | $70 | $64.68 | -0.6% | May 28, 2024 |
| Evercore ISI | Mark Mahaney | $65 | $61.05 | -7.7% | May 17, 2024 |
| Jefferies | James Heaney | $65.5 | $56.52 | -7.0% | May 2, 2024 |
| MoffettNathanson | Michael Nathanson | $50.5 | $61.06 | -28.3% | Apr 19, 2024 |
| Needham | Laura Martin | $70 | $61.06 | -0.6% | Apr 19, 2024 |
| Rosenblatt Securities | Barton Crockett | $54 | $61.06 | -23.3% | Apr 19, 2024 |
| Wells Fargo | Steven Cahall | $72.6 | $61.06 | +3.1% | Apr 19, 2024 |
| Canaccord Genuity | Maria Ripps | $58.5 | $61.06 | -16.9% | Apr 19, 2024 |
| Oppenheimer | Jason Helfstein | $72.5 | $61.06 | +3.0% | Apr 19, 2024 |
| BMO Capital | Brian Pitz | $71.3 | $61.28 | +1.3% | Apr 17, 2024 |
| Rosenblatt Securities | Barton Crockett | $55.4 | $61.75 | -21.3% | Apr 17, 2024 |
| Macquarie | Tim Nollen | $68.5 | $60.97 | -2.7% | Apr 16, 2024 |
| Guggenheim | Michael Morris | $70 | $60.72 | -0.6% | Apr 16, 2024 |
| Deutsche Bank | Bryan Kraft | $55 | $62.28 | -21.9% | Apr 15, 2024 |
| Morgan Stanley | Benjamin Swinburne | $70 | $62.88 | -0.6% | Apr 12, 2024 |
| Piper Sandler | Thomas Champion | $60 | $62.88 | -14.8% | Apr 12, 2024 |
| Morgan Stanley | Michael Cyprys | $31.5 | $62.41 | -55.3% | Apr 9, 2024 |
| Barclays | Kannan Venkateshwar | $55 | $61.82 | -21.9% | Apr 9, 2024 |
| Goldman Sachs | Eric Sheridan | $60 | $62.84 | -14.8% | Apr 9, 2024 |
| Pivotal Research | Jeffrey Wlodarczak | $76.5 | $61.71 | +8.7% | Apr 5, 2024 |
| Wedbush | Analyst unavailable | $72.5 | $62.92 | +3.0% | Mar 27, 2024 |
| Wedbush | Michael Pachter | $72.5 | $61.97 | +3.0% | Mar 27, 2024 |
| Loop Capital Markets | Justin Patterson | $70.5 | $62.07 | +0.1% | Mar 20, 2024 |
| KeyBanc | Justin Patterson | $70.5 | $62.77 | +0.1% | Mar 20, 2024 |
| Evercore ISI | Mark Mahaney | $64 | $60.94 | -9.1% | Mar 13, 2024 |
| Jefferies | Andrew Uerkwitz | $70 | $61.11 | -0.6% | Mar 12, 2024 |
| UBS | John Hodulik | $68.5 | $59.57 | -2.7% | Feb 28, 2024 |
| Seaport Global | David Joyce | $57.6 | $56.18 | -18.2% | Jan 30, 2024 |
| Macquarie | Tim Nollen | $59.5 | $55.18 | -15.5% | Jan 24, 2024 |
| Piper Sandler | Matt Farrell | $47.5 | $48.46 | -32.5% | Jan 18, 2024 |
| Loop Capital Markets | Justin Patterson | $54.5 | $48.12 | -22.6% | Jan 17, 2024 |
| Oppenheimer | Jason Helfstein | $60 | $49.22 | -14.8% | Jan 12, 2024 |
| KeyBanc | Justin Patterson | $52.5 | $49.08 | -25.4% | Dec 28, 2023 |
| Macquarie | Tim Nollen | $41 | $40.47 | -41.8% | Oct 19, 2023 |
| Morgan Stanley | Benjamin Swinburne | $47.5 | $40.18 | -32.5% | Oct 19, 2023 |
| Loop Capital Markets | Justin Patterson | $51 | $34.62 | -27.6% | Oct 19, 2023 |
| Oppenheimer | Jason Helfstein | $47 | $34.88 | -33.2% | Oct 18, 2023 |
| Truist Financial | Matthew Thornton | $43 | $35.57 | -38.9% | Oct 17, 2023 |
| Morgan Stanley | Benjamin Swinburne | $43 | $36.59 | -38.9% | Oct 11, 2023 |
| Wedbush | Michael Pachter | $52.5 | $38.15 | -25.4% | Oct 6, 2023 |
| Oppenheimer | Jason Helfstein | $51.5 | $43.26 | -26.8% | Aug 23, 2023 |
| Robert W. Baird | Vikram Kesavabhotla | $34 | $43.42 | -51.7% | Jul 20, 2023 |
| Wedbush | Michael Pachter | $47.5 | $44.19 | -32.5% | Jul 14, 2023 |
| Rosenblatt Securities | Barton Crockett | $35.7 | $31.92 | -49.3% | Apr 19, 2023 |
| Jefferies | Andrew Uerkwitz | $42.5 | $33.27 | -39.6% | Apr 18, 2023 |
| Morgan Stanley | Ben Swinburne | $35 | $34.57 | -50.3% | Apr 13, 2023 |
| Oppenheimer | Analyst unavailable | $40 | $33.5 | -43.2% | Jan 13, 2023 |
| Jefferies | Andrew Uerkwitz | $38.5 | $32.73 | -45.3% | Jan 12, 2023 |
| Goldman Sachs | Analyst unavailable | $225 | $324.73 | +219.6% | Jan 10, 2023 |
| New Street | Dan Salmon | $30.4 | $29.5 | -56.8% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $275 | $289.13 | +290.6% | Dec 19, 2022 |
| Wells Fargo | Steven Cahall | $40 | $31.03 | -43.2% | Dec 9, 2022 |
| Societe Generale | Analyst unavailable | $215 | $280.96 | +205.4% | Nov 30, 2022 |
| Piper Sandler | Thomas Champion | $270 | $240.86 | +283.5% | Oct 19, 2022 |
| Wedbush | Michael Pachter | $32.5 | $24.09 | -53.8% | Oct 19, 2022 |
| Pivotal Research | Jeffrey Wlodarczak | $200 | $272.38 | +184.1% | Oct 19, 2022 |
| KGI Securities | Freddy Chen | $33 | $27.24 | -53.1% | Oct 19, 2022 |
| Rosenblatt Securities | Barton Crockett | $226 | $272.38 | +221.0% | Oct 19, 2022 |
| Macquarie | Tim Nollen | $285 | $272.38 | +304.8% | Oct 19, 2022 |
| Wolfe Research | Peter Supino | $30.5 | $27.24 | -56.7% | Oct 19, 2022 |
| KGI Securities | Freddy Chen | $33 | $24.09 | -53.1% | Oct 19, 2022 |
| Piper Sandler | Thomas Champion | $270 | $272.38 | +283.5% | Oct 19, 2022 |
| Citigroup | Jason Bazinet | $31.5 | $27.24 | -55.3% | Oct 19, 2022 |
| Macquarie | Tim Nollen | $285 | $272.38 | +304.8% | Oct 19, 2022 |
| Deutsche Bank | Bryan Kraft | $35 | $27.24 | -50.3% | Oct 19, 2022 |
| Credit Suisse | Douglas Mitchelson | $263 | $245.1 | +273.6% | Oct 17, 2022 |
| Wells Fargo | Steven Cahall | $300 | $245.1 | +326.1% | Oct 17, 2022 |
| Wedbush | Michael Pachter | $280 | $230 | +297.7% | Oct 14, 2022 |
| Citigroup | Jason Bazinet | $30.5 | $23 | -56.7% | Oct 14, 2022 |
| Benchmark Co. | Matthew Harrigan | $157 | $232.51 | +123.0% | Oct 13, 2022 |
| Morgan Stanley | Benjamin Swinburne | $230 | $232.51 | +226.7% | Oct 13, 2022 |
| MoffettNathanson | MoffettNathanson MoffettNathanson | $220 | $241.1 | +212.5% | Oct 6, 2022 |
| Atlantic Equities | Hamilton Faber | $283 | $224.36 | +302.0% | Sep 28, 2022 |
| Evercore ISI | Mark Mahaney Mahaney | $300 | $224.55 | +326.1% | Sep 27, 2022 |
| Oppenheimer | Jason Helfstein | $32.5 | $24.01 | -53.8% | Sep 19, 2022 |
| Citigroup | Analyst unavailable | $30.5 | $23.54 | -56.7% | Sep 16, 2022 |
| Macquarie | Tim Nollen | $230 | $228.96 | +226.7% | Sep 7, 2022 |
| CFRA | Kenneth Leon | $238 | $241.16 | +238.1% | Aug 22, 2022 |
| Wells Fargo | Steven Cahall | $145 | $242.7 | +106.0% | Aug 11, 2022 |
| Morgan Stanley | Benjamin Swinburne | $230 | $224.9 | +226.7% | Jul 30, 2022 |
| Loop Capital Markets | Daniel Salmon | $36.5 | $21.35 | -48.2% | Jul 20, 2022 |
| Evercore ISI | Mark Mahaney | $245 | $201.63 | +248.0% | Jul 20, 2022 |
| Pivotal Research | Jeffrey Wlodarczak | $175 | $201.63 | +148.6% | Jul 20, 2022 |
| Atlantic Equities | Hamilton Faber | $211 | $201.63 | +199.7% | Jul 20, 2022 |
| Wedbush | Michael Pachter | $280 | $201.63 | +297.7% | Jul 20, 2022 |
| Citigroup | Jason Bazinet | $275 | $201.63 | +290.6% | Jul 20, 2022 |
| Macquarie | Tim Nollen | $170 | $201.63 | +141.5% | Jul 20, 2022 |
| Wells Fargo | Steven Cahall | $300 | $201.63 | +326.1% | Jul 20, 2022 |
| Piper Sandler | Thomas Champion | $215 | $201.63 | +205.4% | Jul 19, 2022 |
| UBS | John Hodulik | $198 | $186.89 | +181.3% | Jul 15, 2022 |
| Piper Sandler | Thomas Champion | $210 | $174.45 | +198.3% | Jul 13, 2022 |
| Barclays | Kannan Venkateshwar | $170 | $185.38 | +141.5% | Jul 6, 2022 |
| Truist Financial | Matthew Thornton | $210 | $176.33 | +198.3% | Jul 1, 2022 |
| KeyBanc | Brandon Nispel | $151 | $179.6 | +114.5% | Jun 28, 2022 |
| Stifel Nicolaus | Scott Devitt | $240 | $171.58 | +240.9% | Jun 21, 2022 |
| Societe Generale | Christophe Cherblanc | $170 | $166.63 | +141.5% | Jun 14, 2022 |
| Goldman Sachs | Eric Sheridan | $186 | $192.77 | +164.2% | Jun 9, 2022 |
| Guggenheim | Michael Morris | $265 | $205.09 | +276.4% | Jun 2, 2022 |
| Bank of America Securities | Nat Schindler | $240 | $190.56 | +240.9% | May 18, 2022 |
| J.P. Morgan | Doug Anmuth | $300 | $187.64 | +326.1% | May 16, 2022 |
| Citigroup | Analyst unavailable | $295 | $226.19 | +319.0% | Apr 21, 2022 |
| Needham | Analyst unavailable | $30.5 | $22.46 | -56.7% | Apr 20, 2022 |
| Canaccord Genuity | Analyst unavailable | $40 | $21.84 | -43.2% | Apr 20, 2022 |
| Goldman Sachs | Analyst unavailable | $265 | $348.61 | +276.4% | Apr 20, 2022 |
| Truist Financial | Matthew Thornton | $300 | $226.19 | +326.1% | Apr 20, 2022 |
| MoffettNathanson | Michael Nathanson | $245 | $226.19 | +248.0% | Apr 20, 2022 |
| Wedbush | Michael Pachter | $280 | $226.19 | +297.7% | Apr 20, 2022 |
| Morgan Stanley | Benjamin Swinburne | $300 | $226.19 | +326.1% | Apr 20, 2022 |
| BMO Capital | Daniel Salmon | $40.5 | $22.62 | -42.5% | Apr 20, 2022 |
| Rosenblatt Securities | Barton Crockett | $245 | $226.19 | +248.0% | Apr 20, 2022 |
| KGI Securities | Freddy Chen | $35 | $22.62 | -50.3% | Apr 20, 2022 |
| Bank of America Securities | Nat Schindler | $300 | $226.19 | +326.1% | Apr 20, 2022 |
| Guggenheim | Michael Morris | $35 | $22.62 | -50.3% | Apr 20, 2022 |
| Stifel Nicolaus | Scott Devitt | $300 | $226.19 | +326.1% | Apr 20, 2022 |
| Pivotal Research | Jeffrey Wlodarczak | $235 | $226.19 | +233.8% | Apr 20, 2022 |
| Robert W. Baird | William Power | $260 | $226.19 | +269.3% | Apr 20, 2022 |
| Atlantic Equities | Hamilton Faber | $280 | $226.19 | +297.7% | Apr 20, 2022 |
| Cowen & Co. | John Blackledge | $32.5 | $22.62 | -53.8% | Apr 20, 2022 |
| Barclays | Kannan Venkateshwar | $275 | $226.19 | +290.6% | Apr 20, 2022 |
| Rosenblatt Securities | Analyst unavailable | $35.4 | $34.73 | -49.7% | Apr 19, 2022 |
| Credit Suisse | Douglas Mitchelson | $35 | $34.86 | -50.3% | Apr 19, 2022 |
| Loop Capital Markets | Alan Gould | $50 | $34.86 | -29.0% | Apr 19, 2022 |
| Deutsche Bank | Bryan Kraft | $300 | $337.86 | +326.1% | Apr 18, 2022 |
| Wedbush | Michael Pachter | $34.2 | $34.11 | -51.4% | Apr 14, 2022 |
| Morgan Stanley | Benjamin Swinburne | $42.5 | $34.11 | -39.6% | Apr 14, 2022 |
| BMO Capital | Daniel Salmon | $64 | $35.04 | -9.1% | Apr 13, 2022 |
| Cowen & Co. | John Blackledge | $59 | $34.41 | -16.2% | Apr 12, 2022 |
| Truist Financial | Matthew Thornton | $40.9 | $34.8 | -41.9% | Apr 11, 2022 |
| Goldman Sachs | Eric Sheridan | $42 | $34.8 | -40.3% | Apr 11, 2022 |
| J.P. Morgan | Doug Anmuth | $60.5 | $36.22 | -14.1% | Apr 7, 2022 |
| Robert W. Baird | William Power | $42 | $36.22 | -40.3% | Apr 7, 2022 |
| Evercore ISI | Mark Mahaney | $52.5 | $38.06 | -25.4% | Mar 20, 2022 |
| Citigroup | Jason Bazinet | $45 | $42.71 | -36.1% | Jan 31, 2022 |
| Morgan Stanley | Benjamin Swinburne | $45 | $38.44 | -36.1% | Jan 28, 2022 |
| Jefferies | Andrew Uerkwitz | $41.5 | $38.72 | -41.1% | Jan 24, 2022 |
| Argus Research | Joseph Bonner | $57 | $38.72 | -19.0% | Jan 24, 2022 |
| Guggenheim | Michael Morris | $55.5 | $39.75 | -21.2% | Jan 21, 2022 |
| Canaccord Genuity | Maria Ripps | $60 | $39.75 | -14.8% | Jan 21, 2022 |
| BMO Capital | Daniel Salmon | $65 | $39.75 | -7.7% | Jan 21, 2022 |
| Oppenheimer | Jed Kelly | $53 | $39.75 | -24.7% | Jan 21, 2022 |
| Pivotal Research | Jeffrey Wlodarczak | $55 | $39.75 | -21.9% | Jan 21, 2022 |
| Barclays | Kannan Venkateshwar | $42.5 | $39.75 | -39.6% | Jan 21, 2022 |
| Piper Sandler | Thomas Champion | $56.2 | $39.75 | -20.2% | Jan 21, 2022 |
| UBS | John Hodulik | $57.5 | $39.75 | -18.3% | Jan 21, 2022 |
| Truist Financial | Matthew Thornton | $47 | $39.75 | -33.2% | Jan 21, 2022 |
| Credit Suisse | Douglas Mitchelson | $45 | $39.75 | -36.1% | Jan 21, 2022 |
| Cowen & Co. | John Blackledge | $60 | $39.75 | -14.8% | Jan 21, 2022 |
| Bank of America Securities | Nat Schindler | $60.5 | $39.75 | -14.1% | Jan 21, 2022 |
| Wolfe Research | John Janedis | $49.7 | $39.75 | -29.4% | Jan 21, 2022 |
| Deutsche Bank | Bryan Kraft | $46.5 | $39.75 | -33.9% | Jan 21, 2022 |
| Goldman Sachs | Eric Sheridan | $45 | $50.82 | -36.1% | Jan 20, 2022 |
| UBS | John Hodulik | $69 | $52.57 | -2.0% | Jan 15, 2022 |
| Loop Capital Markets | Alan Gould | $70 | $52.57 | -0.6% | Jan 14, 2022 |
| Arete Research | Andrew Beale | $73.5 | $59.75 | +4.4% | Sep 9, 2021 |
| Atlantic Equities | Hamilton Faber | $78 | $60.67 | +10.8% | Sep 7, 2021 |
| Bernstein | Todd Juenger | $61.7 | $50.89 | -12.4% | Apr 21, 2021 |
Track every rating change on NFLX the moment it posts. Free to start.
Start freeFollow NFLX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeNetflix's Q2 2026 results were nearly in-line with a marginal EPS beat of 1.3% and a slight revenue miss of 0.2%. The key change versus prior quarters was the modest deceleration in view-hour growth per member, which raised analyst questions about churn and pricing power. Management raised the floor of its full-year revenue growth range from 12-14% to 13-14%, while quantifying FX-neutral growth at roughly 12%. The bullish score declined from 84 to 78. GenAI tools have now been applied to roughly 300 titles, cutting production time by 50% on some projects, an expansion from the prior quarter's Interpositive acquisition announcement. Live programming continued to drive subscriber acquisition and ad revenue despite low view hours, reinforcing Netflix's strategy of using events as acquisition tools rather than engagement anchors. The company also disclosed $4.7B in Q2 share repurchases with $27B remaining under authorization.
Netflix maintained its full-year 2026 revenue growth guidance, with the low end nudged from 12-14% (prior quarter) to 13-14%. FX-neutral growth was quantified at roughly 12%. Content spend is expected to grow approximately 10%, slower than revenue growth. The prior quarter's operating margin target of 31.5% was not explicitly restated in the Q2 transcript analysis. Guidance sentiment was rated maintained and management tone remained confident.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.